Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lowell Elliott Schnipper, M.D.

Title
Institution
Department
Address
Phone

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01AG003879 (SCHNIPPER, LOWELL E) Jul 1, 1983 - Jun 30, 1987
    NIH
    ACTINIC DAMAGE ON DNA REPAIR IN HUMAN KERATINOCYTES
    Role: Principal Investigator
  2. M01RR001032 (SUKHATME, VIKAS P) Dec 1, 1977 - Mar 31, 2010
    NIH
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Displaying 25 of 140 total Publications Show all
  1. Spring LM, Scarpetti L, Medford AJ, Niemierko A, Comander A, Mulvey T, Schnipper L, Isakoff SJ, Moy B, Wander SA, Shin J, Ephrem Z, Laposta AR, Denault E, Abraham E, Calistro G, Kalashnikova E, Rodriguez A, Liu MC, Aleshin A, Peppercorn J, Ellisen LW, Bardia A. Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER). NPJ Breast Cancer. 2025 Jan 07; 11(1):2. PMID: 39774684; PMCID: PMC11707077.
    Citations:
  2. Thistle P, Parpia R, Pain D, Lee H, Manasa J, Schnipper LE. Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital. JCO Glob Oncol. 2020 08; 6:1276-1281. PMID: 32783640.
    Citations: 2
    Fields: NeoNeoplasmsTranslation:HumansCells
  3. Fish M, Parkes J, Dharsee N, Dryden-Peterson S, Efstathiou J, Schnipper L, Chabner BA, Parikh AR. POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan Africa. Oncologist. 2019 12; 24(12):1557-1561. PMID: 31182656; PMCID: PMC6975941.
    Citations: 8
    Fields: NeoNeoplasmsTranslation:HumansPHPublic Health
  4. Willke RJ, Chapman RH, Seidman JJ, Schnipper LE, Gleason PP. Current Value Frameworks-What's New? Value Health. 2019 06; 22(6S):S7-S11. PMID: 31200806.
    Citations: 1
    Fields: DruDrug TherapyPubPublic HealthTranslation:Humans
  5. Borno H, George DJ, Schnipper LE, Cavalli F, Cerny T, Gillessen S. All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:302-308. PMID: 31099647.
    Citations: 14
    Fields: NeoNeoplasmsTranslation:Humans
  6. Cherny NI, de Vries EGE, Dafni U, Garrett-Mayer E, McKernin SE, Piccart M, Latino NJ, Douillard JY, Schnipper LE, Somerfield MR, Bogaerts J, Karlis D, Zygoura P, Vervita K, Pentheroudakis G, Tabernero J, Zielinski C, Wollins DS, Schilsky RL. Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score. J Clin Oncol. 2019 02 01; 37(4):336-349. PMID: 30707056.
    Citations: 48
    Fields: NeoNeoplasmsTranslation:Humans
  7. Jazieh AR, Al-Saggabi AH, McClung M, Carlson R, Schnipper LE, Eniu A, Blauvelt B, Zafar Y, Kerr D. Facing the Global Challenges of Access to Cancer Medication. J Glob Oncol. 2018 09; 4:1-7. PMID: 30241259.
    Citations: 3
    Fields: NeoNeoplasmsTranslation:HumansPHPublic Health
  8. Schilsky RL, Schnipper LE. Hans Christian Andersen and the Value of New Cancer Treatments. J Natl Cancer Inst. 2018 05 01; 110(5):441-442. PMID: 29244175.
    Citations: 4
    Fields: NeoNeoplasmsTranslation:Humans
  9. Schnipper LE, Schilsky RL. Are Value Frameworks Missing the Mark When Considering Long-term Benefits From Immuno-oncology Drugs? JAMA Oncol. 2018 03 01; 4(3):333-334. PMID: 29285543.
    Citations: 5
    Fields: NeoNeoplasmsTranslation:Humans
  10. Schnipper LE. Direct-to-consumer advertising of cancer treatments. Clin Adv Hematol Oncol. 2017 Oct; 15(10):748-750. PMID: 29040253.
    Citations:
    Fields: HemHematologyNeoNeoplasmsTranslation:Humans
  11. Hortobagyi GN, Pyle D, Cazap EL, El Saghir NS, Shulman LN, Lyman GH, Schnipper LE, Adebamowo CA, Gandara DR, Vose J, Wong SL, Yu P. American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions. J Glob Oncol. 2018 09; 4:1-8. PMID: 30241187.
    Citations: 7
    Fields: NeoNeoplasmsTranslation:Humans
  12. Schnipper LE, Schilsky RL. Converging on the Value of Value Frameworks. J Clin Oncol. 2017 08 20; 35(24):2732-2734. PMID: 28586244.
    Citations: 3
    Fields: NeoNeoplasmsTranslation:Humans
  13. Schnipper LE, Schilsky RL. Reply to J.P. Jansen, A. Messori et al, and H.S.L. Jim et al. J Clin Oncol. 2017 04 01; 35(10):1134. PMID: 28165893.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  14. Gnant M, Van Poznak C, Schnipper L. Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value Assessment. Am Soc Clin Oncol Educ Book. 2017; 37:116-122. PMID: 28561722.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  15. Schnipper LE, Abel GA. Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health. JAMA Oncol. 2016 Nov 01; 2(11):1397-1398. PMID: 27532895.
    Citations: 3
    Fields: NeoNeoplasmsTranslation:Humans
  16. Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open. 2016; 1(5):e000097. PMID: 27843641; PMCID: PMC5070299.
    Citations: 53
  17. Schnipper LE, Bastian A. New Frameworks to Assess Value of Cancer Care: Strengths and Limitations. Oncologist. 2016 06; 21(6):654-8. PMID: 27245568; PMCID: PMC4912372.
    Citations: 15
    Fields: NeoNeoplasmsTranslation:Humans
  18. Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. J Clin Oncol. 2016 08 20; 34(24):2925-34. PMID: 27247218.
    Citations: 227
    Fields: NeoNeoplasmsTranslation:Humans
  19. Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Schilsky RL. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol. 2015 Aug 10; 33(23):2563-77. PMID: 26101248; PMCID: PMC5015427.
    Citations: 308
    Fields: NeoNeoplasmsTranslation:Humans
  20. Schnipper LE, Meropol NJ. Payment for cancer care: time for a new prescription. J Clin Oncol. 2014 Dec 20; 32(36):4027-8. PMID: 25366682.
    Citations: 3
    Fields: NeoNeoplasmsTranslation:Humans
  21. Schnipper LE, Schilsky RL, Hoverman JR, Raghavan D, Lyman GH, Wollins DS, Blayney DW. Reply to L.k. Griffeth et al and J.E. Battley et al. J Clin Oncol. 2014 Sep 01; 32(25):2812-3. PMID: 25024078.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  22. Schnipper LE. Quality oncology practice initiative: an approach to solving the value equation. J Oncol Pract. 2014 May; 10(3):219-20. PMID: 24839286.
    Citations: 1
    Fields: NeoNeoplasmsTranslation:Humans
  23. Schnipper L, Shih YC, Ganz PA. Providing high-quality and affordable intensive care to patients with cancer: The forgotten brick in the steep wall of costs throughout the cancer care continuum. Reply to M. Soares et al. J Clin Oncol. 2014 May 01; 32(13):1384-5. PMID: 24687835.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  24. Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol. 2014 Apr 20; 32(12):1277-80. PMID: 24638016.
    Citations: 157
    Fields: NeoNeoplasmsTranslation:Humans
  25. Schnipper LE, Lyman GH, Blayney DW, Hoverman JR, Raghavan D, Wollins DS, Schilsky RL. American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol. 2013 Dec 01; 31(34):4362-70. PMID: 24170249.
    Citations: 46
    Fields: NeoNeoplasmsTranslation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contact@catalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resources@hms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappt@hms.harvard.edu.
Schnipper's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (597)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.